(1R,2S)-2-Phenylcyclopropanaminium

DB02665ExperimentalSmall molecule

A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It... It also is useful in panic and phobic disorders.

Formula / weight: C₉H₁₂N · 134.1983 g/mol (avg)

Resolves to

Compound

UNII7H4CZX4FYHCAS1986-47-6ChEBI131517PubChem11861988

Structure

InChIKeyAELCINSCMGFISI-DTWKUNHWSA-OSMILES[NH3+][C@@H]1C[C@H]1C1=CC=CC=C1

Targets

P07477PRSS1

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with (1R,2S)-2-Phenylcyclopropanaminium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account